Covid-19 – the UK’s vaccination programme so far (UPDATED)
By EsqSocial Corporation 14/04/21
As I said back in October, delivering a successful Covid-19 vaccine quickly was a huge challenge, but the diversity of the UK’s vaccine portfolio and the amendments made to the Human Medicines Regulations 2012 (HMRs) meant that the UK was in a strong position to carry out a successful mass vaccination programme as soon as a vaccine could demonstrate its safety, quality and efficacy. Six months later, two vaccines have been widely administered in the UK (AstraZeneca/Oxford and Pfizer/BioNTech) –...
By: Allen & Overy LLP